Diabetes Landscape: Market, Technology And Intellectual Property
Prospects for new market entrants
Although the diabetes devices market comprises close to 100 companies, it is dominated by just six major manufacturers: Roche, Johnson & Johnson (J&J), Bayer, Medtronic, Abbott and Becton Dickinson. Given the importance of SMBG in the overall diabetes device market, it follows that most of these companies owe their strong market position to offerings in this area, where brand recognition and a strong sales and marketing presence are vital. Although the significant market positions of the top six companies imply there is little room for smaller companies, there do remain goodopportunities for companies with unique products or devices that compete in yet-to-be established markets.
For example, Insulet has grown its sales from just US$4 million in 2006 to nearly US$120 million in 2011 as a result of offering a unique insulin pump with significant benefits over those offered by the established market leaders. Its OmniPod was the world's first tubing-free insulin pump, meaning it is smaller than many other devices; can be worn more discreetly; eliminates interruptions in insulin delivery due totubing kinks, leaks or disconnections; and, enables patients to move, dress, sleep and exercise more easily. A forensic investigation of 5,900 patents in the diabetes device area has been distilled to provide a detailed assessment of who holds key technology patents worldwide.
This volume provides an in-depth analysis of the technologies and IP associated with diabetes devices, including:Diabetes Monitoring Blood glucose meters and test strips Continuous glucose monitoring Non-invasive and emerging technologies Diabetes Treatment Insulin delivery (including pens and insulin pumps) Open loop continuous glucose monitoring/pumps Closed loop artificial pancreas technology Software & Algorithms There are a significant number (over 500) of patent assignees. This report provides detailed analysis of: Overall diabetes patent portfolio (including Priority Year, Patent Totals by Technology, Top Twenty Assignees, IPC and USP Classifications) Diabetes patents by technology subcategory (including Priority Date, Top Twenty Assignees, and Analysis of Sample Patents) Diabetes patents by key company (including Priority Date, Patent Distribution by Technology, and Patent Source Jurisdiction)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts